RedHill Announces New USPTO Patent Covering Talicia® Through 2034
RedHill's Opaganib Selected for Evaluation by BARDA
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering